Saamya Biotech to raise Rs 15 cr from capital market
Mumbai, Sep 18 (UNI) Hyderabad-based Saamya Biotech Limited will enter the capital market to raise 15 crore to fund a pilot project on bio-pharmaceutical ingredients.
The initial public offer will hit the bourses on September 25 and will close on September 28.
Saamya Biotech plans to set up a manufacturing facility for bio-pharmaceutical ingredients at Shapoorji Palonji Biotech Park at Andhra Pradesh.
The total cost of the project is Rs 28 crore. The State Bank of India has sanctioned a loan of Rs 5 crore while the promoters are contributing Rs 8.08 crore.
Talking
to
mediapersons,
company
managing
director
Dr
Y
M
Reddy
said,
''We
are
a
first
generation
biotech
company
with
an
aim
to
manufacture
and
market
high
value
biopharmaceuticals
and
recombinant
protein
products
of
medical
significance.''
UNI